Definium Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Definium Therapeutics, Inc. (DFTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $2.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-02-26
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2022-12-31 was $2.40M.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2022-09-30 was $1.60M.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2022-06-30 was $1.90M.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2022-03-31 was $3.80M.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $2.70M, a 64.00% decline from fiscal 2024.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $7.50M, a 2.74% increase from fiscal 2023.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $7.30M, a 24.74% decline from fiscal 2022.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $9.70M, a 59.92% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.70M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $7.50M 10-K · filed 2025-03-06 | |||
| 2023-12-31 | $7.30M 10-K · filed 2024-02-28 | |||
| 2022-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $4.00M derived: sum of 2 quarters · filed 2023-03-09 | $5.90M derived: sum of 3 quarters · filed 2023-03-09 | $9.70M 10-K · filed 2023-03-09 |
| 2022-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $3.50M derived: sum of 2 quarters · filed 2022-11-10 | $7.30M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $5.70M 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $3.80M 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | $24.20M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |